The fabulous research from the top clinician and scientists e.g. Dr. Zhong Nanshan (钟南山) who fought in the battle against Covid-19 finally released their newest findings. They demonstrated that LH exerted its anti-coronavirus activity by inhibiting virus replication and reducing the cytokine release from host cells, which supported the clinical use of the medicine in combination with traditional approaches to treat COVID-2019. Lian Hua Qing Wen (莲花清瘟), has been widely used as a broad spectrum of an antiviral agent in the clinical practice, especially for various respiratory virus infections. The famous OTC medicine is available in the form of granulate or capsule. It has shown a broad spectrum of effects on a series of influenza viruses by interfering with both viral and host reactions based on various studies. In February, 2020, it was recommended by the Health Mission of China to use clinically treat Covid-19 in the Sixth Version of Diagnosis and Treatment Protocol for Covid-19《新型冠状病毒肺炎诊疗方案（试行第六版）》.
Function: clear the epidemic pathogen, disperse the toxin in the lungs
Indications: moderate fever or high fever, aversion to cold, muscle pain, stuffing or funning nose, cough, headache, cough, sore or dry throat, red tongue body, yellow with/without greasy coating.
Ingredients: Lian Qiao, Jin Yin Hua, Zhi Ma Huang, (fried) Xin Ren, Shi Gao, Ban Lan Gen, Yu Xing Cao, Guang Huo Xiang, Da Huang, Hong Jing Tian, Bo He (menthol), Gan Cao
Cautions: Can be found in its instruction.
Ding et al. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function, 2017, Open Access
Duan et al. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial, 2011
Lin et al. Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps, 2020
want more? search Lian Hua Qing Wen on scholar.google.com
Li RF, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacological Research. 2020 Mar 20:104761.